![Man in blue button down shirt poses outside for a picture with his arms crossed.](/sites/default/files/styles/featured_square_large/public/2024-07/Troy_Carter_headshot.jpeg?h=8a7fc05e&itok=VFmZIzHo)
Filter News
Area of Research
News Topics
- (-) Biomedical (28)
- (-) Biotechnology (11)
- 3-D Printing/Advanced Manufacturing (39)
- Advanced Reactors (8)
- Artificial Intelligence (46)
- Big Data (24)
- Bioenergy (51)
- Biology (59)
- Buildings (19)
- Chemical Sciences (24)
- Clean Water (14)
- Climate Change (50)
- Composites (6)
- Computer Science (83)
- Coronavirus (17)
- Critical Materials (2)
- Cybersecurity (14)
- Decarbonization (46)
- Education (1)
- Emergency (2)
- Energy Storage (29)
- Environment (104)
- Exascale Computing (25)
- Fossil Energy (4)
- Frontier (24)
- Fusion (31)
- Grid (23)
- High-Performance Computing (44)
- Hydropower (5)
- Isotopes (27)
- ITER (2)
- Machine Learning (22)
- Materials (43)
- Materials Science (45)
- Mathematics (7)
- Mercury (7)
- Microelectronics (2)
- Microscopy (20)
- Molten Salt (1)
- Nanotechnology (16)
- National Security (37)
- Net Zero (8)
- Neutron Science (47)
- Nuclear Energy (55)
- Partnerships (16)
- Physics (28)
- Polymers (8)
- Quantum Computing (20)
- Quantum Science (30)
- Renewable Energy (1)
- Security (11)
- Simulation (31)
- Software (1)
- Space Exploration (12)
- Statistics (1)
- Summit (30)
- Sustainable Energy (44)
- Transformational Challenge Reactor (3)
- Transportation (27)
Media Contacts
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Researchers Adam Guss and Melissa Tumen-Velasquez work with microbes to understand how the organisms consume plastics and break them into chemical components that can be used to make higher-value products.](/sites/default/files/styles/list_page_thumbnail/public/2020-11/2020-P17629.jpg?h=98541007&itok=54ubVna4)
From soda bottles to car bumpers to piping, electronics, and packaging, plastics have become a ubiquitous part of our lives.
![Frontier supercomputer](/sites/default/files/styles/list_page_thumbnail/public/2023-01/frontier_0.jpg?h=a1e1a043&itok=J3IM_Xeh)
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
![coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-11/coronavirus_top10%20%28002%29.png?h=997b30da&itok=7I6TjG_l)
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
![Sandra Davern performs cell based assays to evaluate cell death and DNA damage in response to radiation in order to gain a better understanding of how radioisotope nanoparticles affect the human body.](/sites/default/files/styles/list_page_thumbnail/public/2020-10/2020-P15712.jpg?h=036a71b7&itok=6cpxN4v2)
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
![Enzyme activity during organophosphate poisoning](/sites/default/files/styles/list_page_thumbnail/public/2020-08/anecdote1_0.png?h=d1cb525d&itok=wpYYilBI)
Pick your poison. It can be deadly for good reasons such as protecting crops from harmful insects or fighting parasite infection as medicine — or for evil as a weapon for bioterrorism. Or, in extremely diluted amounts, it can be used to enhance beauty.
![Computational biophysicist Ada Sedova is using experiments and high-performance computing to explore the properties of biological systems and predict their form and function, including research to accelerate drug discovery for COVID-19. Photo credit: Jason Richards, Oak Ridge National Laboratory, U.S. Dept. of Energy.](/sites/default/files/styles/list_page_thumbnail/public/2020-07/2017-P06162Cropped.jpg?h=f1d4573a&itok=TrvR_opt)
Ada Sedova’s journey to Oak Ridge National Laboratory has taken her on the path from pre-med studies in college to an accelerated graduate career in mathematics and biophysics and now to the intersection of computational science and biology